These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119 [TBL] [Abstract][Full Text] [Related]
8. Factor VIII activity in chronic renal disease. Wegmüller E; Grüninger U; Furlan M; Beck EA; Hodler J; Reubi FC Nephron; 1981; 28(4):157-62. PubMed ID: 6795517 [TBL] [Abstract][Full Text] [Related]
9. [Secondary oxalosis in chronic renal insufficiency]. Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142 [TBL] [Abstract][Full Text] [Related]
10. Early elevation of lipoprotein(a) levels in chronic renal insufficiency. De Lima JJ; Maranhão RC; Latrilha Mda C; Diament J; Romão JE; Krieger EM; Pileggi F Ren Fail; 1997 Jan; 19(1):145-54. PubMed ID: 9044461 [TBL] [Abstract][Full Text] [Related]
11. High levels of plasma protein C in nephrotic syndrome. Pabinger-Fasching I; Lechner K; Niessner H; Schmidt P; Balzar E; Mannhalter C Thromb Haemost; 1985 Feb; 53(1):5-7. PubMed ID: 3838827 [TBL] [Abstract][Full Text] [Related]
12. Changes in copper and ceruloplasmin in chronic renal insufficiency treated by hemodialysis and peritoneal dialysis. Bustamante J; Martin Mateo MC; De Paula de Pedro A; Ortiz Manchado O Nephron; 1978; 22(4-6):312-5. PubMed ID: 740091 [TBL] [Abstract][Full Text] [Related]
13. Chromogranin A in uremia: progressive retention of immunoreactive fragments. Hsiao RJ; Mezger MS; O'Connor DT Kidney Int; 1990 Mar; 37(3):955-64. PubMed ID: 2313983 [TBL] [Abstract][Full Text] [Related]
14. [Study of serum ionized calcium and immunoreactive parathyroid hormone in patients with renal disorders]. Chen HJ; Lai YH; Su YH; Tsai JH Gaoxiong Yi Xue Ke Xue Za Zhi; 1985 Mar; 1(3):188-94. PubMed ID: 3871031 [No Abstract] [Full Text] [Related]
15. Factors in the dialysis regimen which contribute to alterations in the abnormalities of uremia. Lowrie EG; Steinberg SM; Galen MA; Gagneux SA; Lazarus JM; Gottlieb MN; Merrill JP Kidney Int; 1976 Nov; 10(5):409-22. PubMed ID: 1003730 [TBL] [Abstract][Full Text] [Related]
16. [Can dialysis be conducted too often?]. Alscher D Dtsch Med Wochenschr; 2003 Feb; 128(9):457. PubMed ID: 12612860 [No Abstract] [Full Text] [Related]
17. [Changes in serum lipoproteins in kidney diseases]. Mordasini R; Riesen W Schweiz Med Wochenschr; 1982 Sep; 112(39):1335-40. PubMed ID: 6755693 [TBL] [Abstract][Full Text] [Related]
18. Geographic factors and plasma selenium in uremia and dialysis. Bonomini M; Forster S; Manfrini V; De Risio F; Steiner M; Vidovich MI; Klinkmann H; Ivanovich P; Albertazzi A Nephron; 1996; 72(2):197-204. PubMed ID: 8684527 [TBL] [Abstract][Full Text] [Related]
19. Regulation of thrombocyte adenylate cyclase activity in terminal renal failure. Lübbecke F; Matthias FR; Wizemann V Thromb Haemost; 1991 Nov; 66(5):623-4. PubMed ID: 1820781 [No Abstract] [Full Text] [Related]